Developmentally altered inhibition in Ts65Dn, a mouse model of Down syndrome

Brain Research

Volumn 1440, Issue , 2012, Pages 1-8

  Mitra, Ananya ^a   Blank, Martina ^a   Madison, Daniel V ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CA1; Down syndrome; Inhibitory synaptic transmission; Postnatal development

Indexed keywords

ACTION POTENTIAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; BRAIN SLICE; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; GENOTYPE; HIPPOCAMPUS; INHIBITORY POSTSYNAPTIC POTENTIAL; MOUSE; NERVE CELL NETWORK; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; PYRAMIDAL TRACT; STRATUM ORIENS; SYNAPTIC TRANSMISSION;

ANIMALS; CA1 REGION, HIPPOCAMPAL; DISEASE MODELS, ANIMAL; DOWN SYNDROME; INHIBITORY POSTSYNAPTIC POTENTIALS; MICE; MICE, MUTANT STRAINS; MINIATURE POSTSYNAPTIC POTENTIALS; NEURAL INHIBITION; PATCH-CLAMP TECHNIQUES; PYRAMIDAL CELLS; RECEPTORS, GABA-A; SYNAPTIC TRANSMISSION; TRISOMY;

ANIMALIA; MUS;

EID: 84857039684     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2011.12.034     Document Type: Article

References (42)

1. S.E. Antonarakis, R. Lyle, E.T. Dermitzakis, A. Reymond, and S. Deutsch Chromosome 21 and down syndrome: from genomics to pathophysiology Nat. Rev. Genet. 5 2004 725 738 (Pubitemid 39336357)
2. L.E. Becker, D.L. Armstrong, and F. Chan Dendritic atrophy in children with Down's syndrome Ann. Neurol. 20 1986 520 526 (Pubitemid 16005672)
3. L. Becker, T. Mito, S. Takashima, and K. Onodera Growth and development of the brain in Down syndrome Prog. Clin. Biol. Res. 373 1991 133 152
4. Y. Ben-Ari Excitatory actions of gaba during development: the nature of the nurture Nat. Rev. Neurosci. 3 2002 728 739 (Pubitemid 135706678)
5. M.A. Canfield, M.A. Honein, N. Yuskiv, J. Xing, C.T. Mai, J.S. Collins, O. Devine, J. Petrini, T.A. Ramadhani, C.A. Hobbs, and R.S. Kirby National estimates and race/ethnic-specific variation of selected birth defects in the United States, 1999-2001 Birth Defects Res. A Clin. Mol. Teratol. 76 2006 747 756
6. L. Chakrabarti, T.K. Best, N.P. Cramer, R.S. Carney, J.T. Isaac, Z. Galdzicki, and T.F. Haydar Olig1 and Olig2 triplication causes developmental brain defects in Down syndrome Nat. Neurosci. 13 2010 927 934
7. A. Contestabile, T. Fila, C. Ceccarelli, P. Bonasoni, L. Bonapace, D. Santini, R. Bartesaghi, and E. Ciani Cell cycle alteration and decreased cell proliferation in the hippocampal dentate gyrus and in the neocortical germinal matrix of fetuses with Down syndrome and in Ts65Dn mice Hippocampus 17 2007 665 678 (Pubitemid 47292037)
8. M.T. Davisson, C. Schmidt, R.H. Reeves, N.G. Irving, E.C. Akeson, B.S. Harris, and R.T. Bronson Segmental trisomy as a mouse model for Down syndrome Prog. Clin. Biol. Res. 384 1993 117 133
9. J. De Felipe, P. Marco, A. Fairen, and E.G. Jones Inhibitory synaptogenesis in mouse somatosensory cortex Cereb. Cortex 7 1997 619 634 (Pubitemid 27467974)
10. F. Fernandez, and C.C. Garner Episodic-like memory in Ts65Dn, a mouse model of Down syndrome Behav. Brain Res. 188 2008 233 237 (Pubitemid 351178776)
11. F. Fernandez, W. Morishita, E. Zuniga, J. Nguyen, M. Blank, R.C. Malenka, and C.C. Garner Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome Nat. Neurosci. 10 2007 411 413 (Pubitemid 46494581)
12. A.C. Granholm, L. Sanders, H. Seo, L. Lin, K. Ford, and O. Isacson Estrogen alters amyloid precursor protein as well as dendritic and cholinergic markers in a mouse model of Down syndrome Hippocampus 13 2003 905 914 (Pubitemid 38100740)
13. S. Guidi, P. Bonasoni, C. Ceccarelli, D. Santini, F. Gualtieri, E. Ciani, and R. Bartesaghi Neurogenesis impairment and increased cell death reduce total neuron number in the hippocampal region of fetuses with Down syndrome Brain Pathol. 18 2008 180 197 (Pubitemid 351430398)
14. A.M. Guihard-Costa, S. Khung, K. Delbecque, F. Menez, and A.L. Delezoide Biometry of face and brain in fetuses with trisomy 21 Pediatr. Res. 59 2006 33 38
15. J.E. Hanson, M. Blank, R.A. Valenzuela, C.C. Garner, and D.V. Madison The functional nature of synaptic circuitry is altered in area CA3 of the hippocampus in a mouse model of Down's syndrome J. Physiol. 579 2007 53 67
16. A.M. Insausti, M. Megias, D. Crespo, L.M. Cruz-Orive, M. Dierssen, I.F. Vallina, R. Insausti, and J. Florez Hippocampal volume and neuronal number in Ts65Dn mice: a murine model of Down syndrome Neurosci. Lett. 253 1998 175 178 (Pubitemid 28442591)
17. T.L. Jernigan, and U. Bellugi Anomalous brain morphology on magnetic resonance images in Williams syndrome and Down syndrome Arch. Neurol. 47 1990 529 533 (Pubitemid 20155841)
18. W.R. Kates, B.S. Folley, D.C. Lanham, G.T. Capone, and W.E. Kaufmann Cerebral growth in Fragile X syndrome: review and comparison with Down syndrome Microsc. Res. Tech. 57 2002 159 167 (Pubitemid 34457295)
19. A.M. Kleschevnikov, P.V. Belichenko, A.J. Villar, C.J. Epstein, R.C. Malenka, and W.C. Mobley Hippocampal long-term potentiation suppressed by increased inhibition in the Ts65Dn mouse, a genetic model of Down syndrome J. Neurosci. 24 2004 8153 8160 (Pubitemid 39280835)
20. D.M. Kullmann Interneuron networks in the hippocampus Curr. Opin. Neurobiol. 5 2011 709 716
21. M.A. Kurt, M.I. Kafa, M. Dierssen, and D.C. Davies Deficits of neuronal density in CA1 and synaptic density in the dentate gyrus, CA3 and CA1, in a mouse model of Down syndrome Brain Res. 1022 2004 101 109 (Pubitemid 39194990)
22. K.B. Larsen, H. Laursen, N. Graem, G.B. Samuelsen, N. Bogdanovic, and B. Pakkenberg Reduced cell number in the neocortical part of the human fetal brain in Down syndrome Ann. Anat. 190 2008 421 427
23. D.P. Liu, C. Schmidt, T. Billings, and M.T. Davisson Quantitative PCR genotyping assay for the Ts65Dn mouse model of Down syndrome Biotechniques 35 2003 1170 1174 1176, 1178 passim
24. H.A. Lorenzi, and R.H. Reeves Hippocampal hypocellularity in the Ts65Dn mouse originates early in development Brain Res. 1104 2006 153 159 (Pubitemid 44148518)
25. M. Marin-Padilla Pyramidal cell abnormalities in the motor cortex of a child with Down's syndrome. A Golgi study J. Comp. Neurol. 167 1976 63 81
26. S. Nurse, and J.C. Lacaille Do GABAA and GABAB inhibitory postsynaptic responses originate from distinct interneurons in the hippocampus? Can. J. Physiol. Pharmacol. 75 1997 520 525 (Pubitemid 27327055)
27. S.E. Parker, C.T. Mai, M.A. Canfield, R. Rickard, Y. Wang, R.E. Meyer, P. Anderson, C.A. Mason, J.S. Collins, R.S. Kirby, and A. Correa Updated National Birth Prevalence estimates for selected birth defects in the United States, 2004-2006 Birth Defects Res. A Clin. Mol. Teratol. 88 2010 1008 1016
28. P. Parra, A.I. Gulyas, and R. Miles How many subtypes of inhibitory cells in the hippocampus? Neuron 20 1998 983 993 (Pubitemid 28247403)
29. B.F. Pennington, J. Moon, J. Edgin, J. Stedron, and L. Nadel The neuropsychology of Down syndrome: evidence for hippocampal dysfunction Child Dev. 74 2003 75 93 (Pubitemid 37244589)
30. J.D. Pinter, W.E. Brown, S. Eliez, J.E. Schmitt, G.T. Capone, and A.L. Reiss Amygdala and hippocampal volumes in children with Down syndrome: a high-resolution MRI study Neurology 56 2001 972 974 (Pubitemid 32290819)
31. J.D. Pinter, S. Eliez, J.E. Schmitt, G.T. Capone, and A.L. Reiss Neuroanatomy of Down's syndrome: a high-resolution MRI study Am. J. Psychiatry 158 2001 1659 1665 (Pubitemid 32923659)
32. G. Pollonini, V. Gao, A. Rabe, S. Palminiello, G. Albertini, and C.M. Alberini Abnormal expression of synaptic proteins and neurotrophin-3 in the Down syndrome mouse model Ts65Dn Neuroscience 156 2008 99 106
33. R.H. Reeves Down syndrome mouse models are looking up Trends Mol. Med. 12 2006 237 240 (Pubitemid 43884991)
34. R.J. Siarey, J. Stoll, S.I. Rapoport, and Z. Galdzicki Altered long-term potentiation in the young and old Ts65Dn mouse, a model for Down Syndrome Neuropharmacology 36 1997 1549 1554 (Pubitemid 28085914)
35. R.J. Siarey, E.J. Carlson, C.J. Epstein, A. Balbo, S.I. Rapoport, and Z. Galdzicki Increased synaptic depression in the Ts65Dn mouse, a model for mental retardation in Down syndrome Neuropharmacology 38 1999 1917 1920 (Pubitemid 29509730)
36. S. Takashima, L.E. Becker, D.L. Armstrong, and F. Chan Abnormal neuronal development in the visual cortex of the human fetus and infant with down's syndrome. A quantitative and qualitative Golgi study Brain Res. 225 1981 1 21 (Pubitemid 11026571)
37. S. Takashima, A. Ieshima, H. Nakamura, and L.E. Becker Dendrites, dementia and the Down syndrome Brain Dev. 11 1989 131 133 (Pubitemid 19106477)
38. R. Tyzio, A. Represa, I. Jorquera, Y. Ben-Ari, H. Gozlan, and L. Aniksztejn The establishment of GABAergic and glutamatergic synapses on CA1 pyramidal neurons is sequential and correlates with the development of the apical dendrite J. Neurosci. 19 1999 10372 10382 (Pubitemid 30228044)
39. N. Whittle, S.B. Sartori, M. Dierssen, G. Lubec, and N. Singewald Fetal Down syndrome brains exhibit aberrant levels of neurotransmitters critical for normal brain development Pediatrics 120 2007 e1465 e1471
40. T.C. Winter, A.A. Ostrovsky, C.A. Komarniski, and S.B. Uhrich Cerebellar and frontal lobe hypoplasia in fetuses with trisomy 21: usefulness as combined US markers Radiology 214 2000 533 538 (Pubitemid 30077715)
41. K.E. Wisniewski Down syndrome children often have brain with maturation delay, retardation of growth, and cortical dysgenesis Am. J. Med. Genet. Suppl. 7 1990 274 281
42. R.S. Zucker, and W.G. Regehr Short-term synaptic plasticity Annu. Rev. Physiol. 64 2002 355 405 (Pubitemid 34259234)